AU2001267831A1 - DDS compound and process for the preparation thereof - Google Patents
DDS compound and process for the preparation thereofInfo
- Publication number
- AU2001267831A1 AU2001267831A1 AU2001267831A AU6783101A AU2001267831A1 AU 2001267831 A1 AU2001267831 A1 AU 2001267831A1 AU 2001267831 A AU2001267831 A AU 2001267831A AU 6783101 A AU6783101 A AU 6783101A AU 2001267831 A1 AU2001267831 A1 AU 2001267831A1
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- dds compound
- dds
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-195919 | 2000-06-29 | ||
| JP2000195919 | 2000-06-29 | ||
| PCT/JP2001/005498 WO2002000734A1 (en) | 2000-06-29 | 2001-06-27 | Dds compound and process for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001267831A1 true AU2001267831A1 (en) | 2002-01-08 |
Family
ID=18694503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001267831A Abandoned AU2001267831A1 (en) | 2000-06-29 | 2001-06-27 | DDS compound and process for the preparation thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030166513A1 (en) |
| EP (1) | EP1298145A4 (en) |
| KR (1) | KR20030031502A (en) |
| CN (1) | CN1449412A (en) |
| AU (1) | AU2001267831A1 (en) |
| BR (1) | BR0112287A (en) |
| CA (1) | CA2412582A1 (en) |
| IL (1) | IL153505A0 (en) |
| MX (1) | MXPA02012791A (en) |
| NO (1) | NO20026212L (en) |
| WO (1) | WO2002000734A1 (en) |
| ZA (1) | ZA200300743B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2195648A1 (en) | 1994-07-25 | 1996-02-08 | Christoph Seidel | Metal chelate-labelled peptides |
| PL221351B1 (en) | 2012-03-14 | 2016-03-31 | Politechnika Warszawska | Method for obtaining polysaccharide nanoparticles |
| WO2014057687A1 (en) | 2012-10-11 | 2014-04-17 | 第一三共株式会社 | Antibody-drug conjugate |
| JP6272230B2 (en) * | 2012-10-19 | 2018-01-31 | 第一三共株式会社 | Antibody-drug conjugate conjugated with a linker containing a hydrophilic structure |
| CA2933666C (en) | 2013-12-25 | 2021-08-03 | Sapporo Medical University | Anti-trop2 antibody-drug conjugate |
| KR102362920B1 (en) | 2014-01-31 | 2022-02-14 | 다이이찌 산쿄 가부시키가이샤 | Anti-her2 antibody-drug conjugate |
| JP2017114763A (en) * | 2014-03-26 | 2017-06-29 | 第一三共株式会社 | Anti-CD98 antibody-drug conjugate |
| WO2015155976A1 (en) * | 2014-04-10 | 2015-10-15 | 第一三共株式会社 | (anti-her2 antibody)-drug conjugate |
| SG11201608309PA (en) | 2014-04-10 | 2016-11-29 | Daiichi Sankyo Co Ltd | Anti-her3 antibody-drug conjugate |
| IL290959B2 (en) | 2015-06-29 | 2023-04-01 | Daiichi Sankyo Co Ltd | Antibody-drug conjugate compisitions and methods for producing same |
| FR3045608A1 (en) * | 2015-12-18 | 2017-06-23 | Rhodia Operations | DEXTRANE CARBOXYL |
| CN110049779A (en) | 2016-12-12 | 2019-07-23 | 第一三共株式会社 | The combination of antibody-drug conjugates and immunologic test point inhibitor |
| CA3050668C (en) | 2017-01-17 | 2023-08-15 | Daiichi Sankyo Company, Limited | Anti-gpr20 antibody and anti-gpr20 antibody-drug conjugate |
| TW202330036A (en) | 2017-05-15 | 2023-08-01 | 日商第一三共股份有限公司 | Manufacturing method of antibody-drug conjugates |
| IL272964B2 (en) | 2017-08-31 | 2024-02-01 | Daiichi Sankyo Co Ltd | Method for producing antibody-drug conjugate |
| KR20200041993A (en) | 2017-08-31 | 2020-04-22 | 다이이찌 산쿄 가부시키가이샤 | Method for improved production of antibody-drug conjugates |
| RS64379B1 (en) | 2018-05-18 | 2023-08-31 | Glycotope Gmbh | Anti-muc1 antibody |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT640622E (en) * | 1993-02-26 | 2000-11-30 | Drug Delivery System Inst Ltd | POLYCARKARID DERIVATIVES AND PHARMACEUTICAL VEHICLES |
| SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
| TW409058B (en) * | 1996-06-06 | 2000-10-21 | Daiichi Seiyaku Co | Method for preparation of a drug complex |
| TW527183B (en) * | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
| EP1080732A4 (en) * | 1998-05-22 | 2004-08-25 | Daiichi Seiyaku Co | Drug composites |
| MXPA01004239A (en) * | 1998-10-30 | 2002-06-04 | Daiichi Seiyaku Co | Dds compounds and method for assaying the same. |
| MXPA03000387A (en) * | 2000-07-13 | 2003-09-22 | Daiichi Seiyaku Co | Pharmaceutical compositions containing dds compounds. |
-
2001
- 2001-06-27 KR KR1020027017768A patent/KR20030031502A/en not_active Application Discontinuation
- 2001-06-27 IL IL15350501A patent/IL153505A0/en unknown
- 2001-06-27 CN CN01814617A patent/CN1449412A/en active Pending
- 2001-06-27 US US10/297,584 patent/US20030166513A1/en not_active Abandoned
- 2001-06-27 EP EP01945629A patent/EP1298145A4/en not_active Withdrawn
- 2001-06-27 CA CA002412582A patent/CA2412582A1/en not_active Abandoned
- 2001-06-27 BR BR0112287-8A patent/BR0112287A/en not_active Application Discontinuation
- 2001-06-27 WO PCT/JP2001/005498 patent/WO2002000734A1/en not_active Application Discontinuation
- 2001-06-27 AU AU2001267831A patent/AU2001267831A1/en not_active Abandoned
- 2001-06-27 MX MXPA02012791A patent/MXPA02012791A/en unknown
-
2002
- 2002-12-23 NO NO20026212A patent/NO20026212L/en not_active Application Discontinuation
-
2003
- 2003-01-28 ZA ZA200300743A patent/ZA200300743B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1449412A (en) | 2003-10-15 |
| ZA200300743B (en) | 2004-02-10 |
| EP1298145A4 (en) | 2004-12-08 |
| IL153505A0 (en) | 2003-07-06 |
| NO20026212D0 (en) | 2002-12-23 |
| US20030166513A1 (en) | 2003-09-04 |
| BR0112287A (en) | 2003-05-06 |
| EP1298145A1 (en) | 2003-04-02 |
| KR20030031502A (en) | 2003-04-21 |
| NO20026212L (en) | 2003-02-06 |
| MXPA02012791A (en) | 2003-12-11 |
| WO2002000734A1 (en) | 2002-01-03 |
| CA2412582A1 (en) | 2002-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001240115A1 (en) | Method for the preparation of tetrahydrobenzothiepines | |
| AU2002218503A1 (en) | Powdery preparations and methods for producing the same | |
| AU6230501A (en) | Propylene polymers and process for the preparation thereof | |
| AU2001267831A1 (en) | DDS compound and process for the preparation thereof | |
| AU2001273762A1 (en) | Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols | |
| AU7446900A (en) | Thioalkylamine derivatives and process for the preparation thereof | |
| AU2001252671A1 (en) | Pyridobenzodiazine derivatives and processes for the preparation thereof | |
| AU2691200A (en) | Isoxazoline compounds and processes for the preparation thereof | |
| AU2001264385A1 (en) | Novel cephalosporin compounds and process for preparing the same | |
| AU2002218494A1 (en) | Medicinal compositions and process for producing the same | |
| AU2001260083A1 (en) | New pharmaceutical composition and the process for its preparation | |
| AU3841500A (en) | Resin-bearing ketoamides and process for the preparation thereof | |
| AU2002212582A1 (en) | Process for preparing (-)- menthol and similar compounds | |
| AU5462901A (en) | Process for the preparation of (pyridinylidene)-phthalides | |
| AU6875800A (en) | Heterocyclic compounds and process for the preparation thereof | |
| AU2401401A (en) | Migrastatin, process for producing the same and medicinal compositions | |
| AU4781000A (en) | 6-hydroxy-2-naphthylcarbinol and process for the preparation thereof | |
| AU6593700A (en) | Quinoline compounds and process for producing the same | |
| AU2000258438A1 (en) | An improved process for the preparation of acylferrocenes | |
| AU2000279379A1 (en) | An improved process for the preparation of 10h-phenoxazine | |
| AU2001264384A1 (en) | Novel cephalosporin compounds and process for preparing the same | |
| AU2002221114A1 (en) | Novel ss-lactam compounds and process for preparing the same | |
| AU2001256774A1 (en) | Thiazolylethanone compounds and process for the preparation thereof | |
| AU2001227071A1 (en) | Novel substance m-17a and process for producing the same | |
| AU2000228300A1 (en) | Novel substance fki-0076 and process for producing the same |